Measles virus: Evidence for association with lung cancer

Experimental Lung Research

Volumn 35, Issue 8, 2009, Pages 701-712

  Sion Vardy, Netta ^a   Lasarov, Irena ^a   Delgado, Bertha ^a   Gopas, Jacob ^b   Benharroch, Daniel ^a   Ariad, Samuel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Immunohistochemistry; Measles virus; Non small cell lung cancer; P53; Pirh2

Indexed keywords

AVIDIN; BIOTIN; PEROXIDASE; PIRH2 PROTEIN; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEASLES VIRUS; PATHOLOGY; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, VIRAL; CARCINOMA, NON-SMALL-CELL LUNG; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MEASLES VIRUS; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 70449512553     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902140902853176     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer Statistics 2007. CA Cancer J Clin. 2007;57:43-66.
2. Baron-Epel O, Andreev H, Barchana M, Green MS: Smoking and incidence of lung cancer in Israel, 1981-1995 [in Hebrew]. Harefuah. 1999;136:522-527.
3. Patel JD, Bach PB, Kris MG: Lung cancer in US women: A contemporary epidemic. JAMA. 2004;291:1763-1768.
4. Boyle P, Maissonneuve P: Lung cancer and tobacco smoking. Lung Cancer. 1995;12:167-181.
5. Alberg AJ, Samet JM: Epidemiology of lung cancer. Chest. 2003;123:21S-49S.
6. Kreuzer M, Keienbrock L, Gerken M. Risk factors for lung cancer in young adults. AmJ Epidemiol. 1998;147:1028-1037.
7. Syrjanen KJ. HPV infections and lung cancer. J Clin Pathol. 2002;55:885-891.
8. Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E, et al: Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res. 2002;62:4876-4878.
9. Galateau-Salle F, Bidet P, Iwatsubo Y, Gennetay E, Renier A, Letourneux M, et al: Detection of SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma and other pulmonary diseases. Dev Biol Stand. 1998;94:147-152.
10. Brouchet L, Valmary S, Dahan M, Didier A, Galateau-Salle F, Brousset P, et al: Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer. 2005;92:743-746.
11. Giuliani L, Jaxmar T, Casadio C, Gariglio M, Manna A, D'Antonio D, et al: Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer. 2007;57:273-281.
12. Yousem SA, Finkelstein SD, Swalsky PA, Bakker A, Ohori NP: Absence of Jaagsiekte retrovirus DNA and RNA in bronchoalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol. 2001;32:1039-1042.
13. Benharroch D, Shemer-Avni Y, Myint YY, Levy A, Mejirovsky E, Suprun I, et al: Measles virus: Evidence of an association with Hodgkin's disease. Br J Cancer. 2004;91:572-579.
14. Rima BK, Paul Duprex W: Molecular mechanism of measles virus persistence. Virus Res. 2005;111:132-147.
15. Chen M, Cortay JC, Logan IR, Sapountzi V, Robson CN, Gerlier D: Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein. J Virol. 2005;79:11824-11836.
16. Duan W, Gao L, Druham LJ, Zhu W, Morrison C, Otterson GA, et al: Expression of Pirh2, a newly identified ubiquitin protein ligase in lung cancer. J Nat Cancer Inst. 2004;96:1718-1721.
17. Varsano S, Rashkovsky L, Shapiro H, Ophir D, Mark-Bentankur T: Human lung cancer lines express cell membrane complement inhibitory proteins and are extremely resistant to complementmediated lysis: A comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance. Clin Exp Immunol. 1998;113:173-182.
18. Schneider-Schaulies S, Kreth HW, Hofmann G, Billeter M, Ter Meulen V: Expression of measles virus RNA in peripheral blood mononuclear cells of patients with measles, SSPE, and autoimmune diseases. Virology. 1991;182:703-711.
19. Matsuoka M: Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene. 2003;22:5131-5140. (Pubitemid 37059594)
20. Ganem D: KSHV and Kaposi's sarcoma: The end of the beginning? Cell. 1997;91:157-160.
21. Zur Hausen H: Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690-698.
22. Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, et al: The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001;61:2799-2803.
23. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, et al: Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell. 2003;112:779-791.
24. Haupt Y, Maya R, Kazaz A, Oren M: Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296-299.